Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms

Lung Cancer

Volumn 74, Issue 2, 2011, Pages 239-243

  Terzi, Alberto ^a   Bertolaccini, Luca ^a   Rizzardi, Giovanna ^a   Luzzi, Luca ^b   Bianchi, Andrea ^a   Campione, Andrea ^a   Comino, Alberto ^a   Biggi, Alberto ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Non parametric statistics; PET CT; Thymic epithelial neoplasm

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYMOMA; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053643536     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.02.018     Document Type: Article

References (22)

1. Chen G., Marx A., Wen-Hu C., Yong J., Puppe B., Stroebel P., et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002, 95:420-429.
2. Rosai J., Sobin L. Histological typing of tumors of the thymus. World Health Organization, international histological classification of tumors 1999, 9-14. Springer, Berlin/New York. J. Rosai, L. Sobin (Eds.).
3. Okumura M., Ohta M., Tateyama H., Nakagawa K., Matsumura A., Maeda H., et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002, 94:624-632.
4. Nakagawa K., Asamura H., Matsuno Y., Suzuki K., Kondo H., Maeshima A., et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003, 126:1134-1140.
5. Tomiyama N., Johkoh T., Mihara N., Honda O., Kozuka T., Koyama M., et al. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings. Am J Roentgenol 2002, 179:881-886.
6. Jeong Y.J., Lee K.S., Kim J., Shim Y.M., Han J., Kwon O.J. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?. Am J Roentgenol 2004, 183:283-289.
7. Rea F., Marulli G., Girardi R., Bortolotti L., Favaretto A., Galligioni A., et al. Long-term survival and prognostic factors in thymic epithelial tumors. Eur J Cardiothorac Surg 2004, 26:412-418.
8. Marchevsky A.M., Gupta R., McKenna R.J., Wick M., Moran C., Zakowski M.F., et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 2008, 112:2780-2788.
9. Sung Y.M., Lee K.S., Kim B.T., Choi J.Y., Shim Y.M., Yi C.A. 18F-FDG PET of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006, 47:16-34.
10. Endo M., Nakagawa K., Ohde Y., Okumura T., Kondo H., Igawa S., et al. Utility of 18F-FDG PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008, 61:350-355.
11. Kumar A., Regmi S.K., Dutta R., Kumar R., Gupta S.D., Das P., et al. Characterization of thymic masses using 18F-FDG PET/CT. Ann Nucl Med 2009, 23:569-577.
12. Igai H., et al. Usefulness of [18F] fluoro-2-deoxy-d-glucose-positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors. Eur J Cardiothorac Surg 2010, 10.1010/j.ejcts.2010.09.009.
13. Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981, 48:2485-2492.
14. Luzzi L., Campione A., Gorla A., Vassallo G., Bianchi A., Biggi A., et al. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses. Eur J Cardiothorac Surg 2009, 36:475-479.
15. Anderson T.W. An introduction to multivariate statistical analysis 1958, John Wiley & Sons, New York, p. 126-31.
16. Cohen J. Statistical power analysis for the behavioral sciences 1988, Erlbaum, Hillsdale, NJ. 2nd ed.
17. Rizzardi G., Campione A., Scanagatta P., Terzi A. Paraneoplastic extra limbic encephalitis associated with thymoma. Interact Cardiovasc Thorac Surg 2009, 9:755-756.
18. Sonobe S., Miyamoto H., Izumi H. Clinical usefulness of the WHO histological classification of thymoma. Ann Thorac Cardiovasc Surg 2005, 11:367-373.
19. Wright C.D., Choi N.C., Wain J.C., Mathisen D.J., Lynch T.J., Fidias P. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 2008, 85:385-389.
20. Cardillo G., Carleo F., Giunti R., Lopergolo M.G., Salvadori L., De Massimi A.R., et al. Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa). Eur J Cardiothorac Surg 2009, 36:914-918.
21. Detterbeck F.C. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006, 81:2328-2334.
22. Kaiser L.R. Thymoma. The use of minimally invasive resection techniques. Chest Surg Clin N Am 1994, 4:185-194.